Medfiles

Executive Summary

Medfiles is a Finnish consulting firm established in 1987, specializing in regulatory affairs, clinical research, and pharmacovigilance for human and veterinary medicines, medical devices, IVDs, and food/feed products. With over 35 years of experience, the company provides practical and flexible solutions to support clients through product development, registration, and post-market activities, navigating complex regulatory landscapes. As a private company headquartered in Turku, Finland, Medfiles serves businesses of all sizes, leveraging deep expertise in EU and global regulations. The firm is well-positioned to capitalize on the growing demand for regulatory consulting services, driven by increasing regulatory complexity and the need for compliance in life sciences. However, as a service-based company without proprietary products, its growth is tied to client engagements and market trends in drug and device development. Medfiles' long track record and niche specialization provide a stable foundation, but scalability may be limited compared to product-focused firms. Overall, Medfiles represents a steady, low-risk opportunity in the regulatory consulting space, with potential for moderate growth as regulatory burdens intensify.

Upcoming Catalysts (preview)

• Q4 2026Expansion of Services Under EU MDR and IVDR80% success
• Q2 2027Strategic Partnership or Acquisition to Broaden Geographical Reach50% success
• Q3 2026Increased Demand for Pharmacovigilance Services Post-COVID70% success